与代谢相关的基因PDK1调节心肌细胞重塑及其机制
Saleem Amina1,2, Mingyu Wei3, Siyao Zhang1,4
1Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Stem cell research & therapy
|July 27, 2025
概括
我们创建了一个缺乏Pyruvate脱酶激酶1 (PDK1) 的人类心脏细胞模型. 这种模型揭示了PDK1缺乏在低氧条件下导致细胞死亡,为心脏病机制提供了洞察力.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体的新陈代谢
- 基因编辑技术的技术
背景情况:
- 缺血性心脏病涉及心脏重塑和心肌病变.
- 酸盐脱酶激酶1 (PDK1) 对于氧化酸化至关重要.
- 缺少PDK1淘汰赛 (KO) 的人类模型来研究其在疾病中的作用.
研究的目的:
- 建立一个人体PDK1缺陷心肌细胞 (CM) 模型.
- 研究PDK1在缺氧诱导的心肌亡中的作用.
- 阐明心脏细胞中PDK1缺乏的潜在机制.
主要方法:
- 利用了CRISPR/Cas-9基因编辑和人类诱导的多能干细胞 (hiPSC).
- 对hiPSCs的定向分化产生PDK1-KO CMs.
- 在基底和缺氧条件下评估病理特征.
主要成果:
- PDK1的淘汰并没有影响hiPSC的多能性或分化.
- 缺乏PDK1的CMs表现出缺氧诱导的亡,线粒体代谢受损,氧化应激增加,活力降低.
- 病毒传染改善了PDK1缺乏的CMs中的新陈代谢和活力.
结论:
- 在低氧状态下成功建立了人类PDK1-KO CM模型.
- 该模型证明了线粒体功能障碍,氧化应激和生命能力下降.
- 这个模型有助于理解缺氧诱导的亡和PDK1缺乏机制.
更多相关视频
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.2K
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
8.8K
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
